 Checkpoint Therapeutics, Inc. Checkpoint CKPT, a clinical-stage immunotherapy and targeted oncology company, today announced that it will host the Companys 2020 Annual Meeting of Stockholders the Annual Meeting virtually due to public health concerns resulting from the coronavirus COVID-19 outbreak, and government-recommended and required limits on public gatherings. Holding the meeting online will also protect the health and safety of the Companys stockholders, directors and employees. The Annual Meeting of Stockholders will begin at 10:00 a.m. Eastern Time on Thursday, June 4, 2020, and will be conducted in a virtual format only. 